BioCentury
ARTICLE | Company News

Management tracks

October 11, 2014 2:05 AM UTC

Roth Capital Partners named John Chambers vice-chairman. Chambers, who joined ROTH in 2009, remains head of its healthcare investment banking group. He was previously the head of the healthcare and investment banking team at Merriman Curhan Ford.

New Enterprise Associates hired Carol Gallagher as a partner. Gallagher was previously a venture partner at Frazier Healthcare, and was CEO of Calistoga Therapeutics Inc., which was acquired by Gilead Sciences Inc. (NASDAQ:GILD) in 2011. She is also chairman of Atara Biotherapeutics Inc. (Brisbane, Calif.) and AnaptysBio Inc. (San Diego, Calif.) and director at Atterocor Inc. (Ann Arbor, Mich.). ...